{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1381137045608920320.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"C. A. (CAB) Bond"}],"foaf:familyName":[{"@value":"Bond"}],"foaf:givenName":[{"@value":"C. A. (CAB)"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1361137045608920320","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.2146/ajhp040555"},{"@type":"URI","@value":"http://academic.oup.com/ajhp/article-pdf/62/15/1596/28323475/ajhp1596.pdf"}],"notation":[{"@value":"Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapy"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.2146/ajhp040555_O6ADpBsoaVlTAVSqtAXELEGVqp6"}]}